Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma [Phase 2]
Phase 2 trial of BEAM chemotherapy regimen followed by autologous stem cell transplantation for lymphoma is completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma [Phase 1, Phase 2]
This clinical trial update summarizes Phase 1/2 results for intravenous AMD3100 (plerixafor) used to collect autologous peripheral blood ste…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating the impact of a nutritional program during autologous stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine in combination with rituximab, vincristine, and cyclophosphamide for refractory lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating chemotherapy with low-dose radiation for pediatric Hodgkin lymphoma has completed; results posted in 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial update for SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma [Phase 3]
This Phase 3 trial update reports the termination of a study comparing three regimens in previously untreated Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit [Phase 1]
This update reports the completion of a Phase 1 trial evaluating a single treatment with FT1050, an ex-vivo modulated umbilical cord blood u…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory
This clinical trial update reports termination of a study evaluating PET-based and donor-based consolidation after salvage therapy in patien…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease [Phase 2]
Phase 2 clinical trial update evaluating treatment in young patients with newly diagnosed, low-stage lymphocyte-predominant Hodgkin disease.…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
An early-phase study of flavopiridol (alvocidib) in patients with relapsed or refractory lymphoma or multiple myeloma; the Phase 1/2 trial w…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]
A clinical trial update for a combination chemotherapy approach in relapsed or refractory Hodgkin lymphoma, spanning Phase 1 and Phase 2, wi…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) [Phase 3]
Phase III randomized, double-blind, placebo-controlled multicenter trial evaluating panobinostat as maintenance therapy in Hodgkin lymphoma …
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy for newly diagnosed stage I or stage II Hodgkin's lymphoma; the study stat…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies [Phase 1]
Phase 1 safety study evaluating a natural killer (NK) cell line for hematologic cancers has completed, assessing its use against leukemia, l…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors [EARLY_Phase 1]
Early-phase 1 clinical trial update for nelfinavir in gammaherpesvirus-related tumors, noting termination of the study despite investigation…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
This Clinical Trial Update reports on biomarker analyses in blood and tissue samples from patients with Epstein-Barr Virus-positive Hodgkin …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
This completed clinical trial evaluated protein biomarker levels in tissue samples from young patients with low-risk Hodgkin lymphoma to ide…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
A Duke University registry study evaluating T-cell depleted allogeneic non-myeloablative stem cell transplantation for hematologic cancers h…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies [Phase 2]
Phase 2 clinical trial update on mismatched family member donor stem cell transplantation in children and young adults with high-risk hemato…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Quality of Life Among Survivors of Hodgkin Lymphoma
A completed clinical trial assessing quality of life among survivors of Hodgkin lymphoma. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating treosulfan-based conditioning for allogeneic stem cell transplantation in lymphoid malignancies is being updated. T…